- Filed
- Mar 12, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Mar 12, 2024 | 31.9M sh |
| Stock Issued | Q1 2024 · Jan 31, 2024 | 555.82K sh |
| Short Term Investments | Q1 2024 · Jan 31, 2024 | $22.8M |
| Short Term Investments | Q1 2024 · Oct 31, 2023 | $22.93M |
| Cash And Equivalents | Q1 2024 · Jan 31, 2024 | $998K |
| Cash And Equivalents | Q1 2024 · Oct 31, 2023 | $915K |
| Stockholders Equity | Q1 2024 · Jan 31, 2024 | $24.61M |
| Stockholders Equity | Q1 2024 · Oct 31, 2023 | $24.34M |
| Current Liabilities | Q1 2024 · Jan 31, 2024 | $1.66M |
| Current Liabilities | Q1 2024 · Oct 31, 2023 | $2.03M |
| Total Liabilities | Q1 2024 · Jan 31, 2024 | $1.77M |
| Total Liabilities | Q1 2024 · Oct 31, 2023 | $2.15M |
| Current Assets | Q1 2024 · Jan 31, 2024 | $25.22M |
| Current Assets | Q1 2024 · Oct 31, 2023 | $25.36M |
| Total Assets | Q1 2024 · Jan 31, 2024 | $25.37M |
| Total Assets | Q1 2024 · Oct 31, 2023 | $25.52M |
| Shares Diluted | Q1 2024 · Jan 31, 2023 | 30.92K sh |
| Operating Cash Flow | Q1 2024 · Jan 31, 2023 | −$1.99M |
| Eps Diluted | Q1 2024 · Jan 31, 2023 | $0.08 |
| Eps Basic restated | Q1 2024 · Jan 31, 2023 | $0.08 |
| Rd Expense | Q1 2024 · Jan 31, 2023 | $1.07M |
| Net Income | Q1 2024 · Jan 31, 2023 | −$2.32M |
| Operating Income | Q1 2024 · Jan 31, 2023 | −$2.56M |